Ebpay生命医药出版社

    Ebpay生命

    100763

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.3 Breast Cancer (Dove Med Press)
    • 3.4 Clin Epidemiol
    • 2.5 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.5 Clin Interv Aging
    • 4.7 Drug Des Dev Ther
    • 2.7 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.5 Int J Women's Health
    • 2.5 Neuropsych Dis Treat
    • 2.7 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.3 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 2.8 Diabet Metab Synd Ob
    • 2.8 Psychol Res Behav Ma
    • 3.0 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.7 Risk Manag Healthc Policy
    • 4.2 J Inflamm Res
    • 2.1 Int J Gen Med
    • 4.2 J Hepatocell Carcinoma
    • 3.7 J Asthma Allergy
    • 1.9 Clin Cosmet Investig Dermatol
    • 2.7 J Multidiscip Healthc



    更多详情 >>





    视频

    Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

     

    Authors Liu W, Wang S, Xia X

    Received 9 November 2021

    Accepted for publication 7 December 2021

    Published 16 December 2021 Volume 2021:14 Pages 9923—9929

    DOI http://doi.org/10.2147/IJGM.S346143

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 3

    Editor who approved publication: Dr Scott Fraser

    Purpose: Although the prognosis of papillary thyroid microcarcinoma (PTMC) is excellent, cervical lymph node metastasis (CLNM) is commonly observed in PTMC. This study aimed to investigate the incidence and risk factors for CLNM in PTMC.
    Patients and Methods: Altogether, 687 patients with PTMC who initially underwent unilateral thyroidectomy with unilateral central lymph node dissection or bilateral thyroidectomy with bilateral central lymph node dissection between January 2014 and June 2018 at our hospital were included. The patients were divided into two groups: PTMC with CLNM and PTMC with no CLNM. The clinicopathologic characteristics and ultrasound features were compared between the groups. Univariate and multivariate logistic regression analyses were used to identify the risk factors for CLNM.
    Results: CLNM was observed in 121/687 (17.6%) patients with PTMC. PTMC patients aged < 55 years exhibited a greater incidence of CLNM (87.6% vs 12.4%) than those aged ≥ 55 years. PTMC patients with CLNM were more likely to have capsular extension (24.0% vs 15.4%) and extension to the adjacent structures (9.9% vs 4.2%). Patients with microcalcification on ultrasound images were more likely to have CLNM (66.1% vs 47.9%). Multivariate logistic regression analysis revealed that microcalcification (odds ratio [OR]: 2.066, 95% confidence interval [CI]: 1.361– 3.135, < 0.001), age < 55 years (OR: 2.341, 95% CI: 1.309– 4.187, =0.004), capsular invasion (OR: 1.772, 95% CI: 1.082– 2.879, =0.023), and invasion of the adjacent tissues (OR: 2.872, 95% CI: 1.355– 4.187, =0.004) were significant risk factors for CLNM.
    Conclusion: Microcalcification, age < 55 years, capsular invasion, and invasion of the adjacent tissues were significant risk factors for CLNM in PTMC.
    Keywords: risk factors, papillary thyroid microcarcinoma, microcalcification, age, invasion




    Download Article[PDF]